Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Pseudomembranous conjunctivitis, left eye
Summary
Pseudomembranous conjunctivitis, left eye, is a severe form of conjunctival inflammation affecting the left eye, characterized by the formation of a pseudomembrane—a layer of inflammatory exudate adhering to the conjunctiva. It typically presents with marked redness, irritation, and discharge, and requires prompt clinical attention due to associated discomfort and potential complications.
Causes
Pseudomembranous conjunctivitis can result from various infectious or inflammatory processes. Common causes include bacterial infections (e.g., Corynebacterium diphtheriae, Streptococcus pneumoniae), viral infections (e.g., adenovirus), or severe allergic reactions. The pseudomembrane forms due to the accumulation of fibrin, inflammatory cells, and debris on the conjunctival surface.
Risk Factors
- Severe bacterial or viral infections of the eye.
- Untreated or poorly managed conjunctivitis.
- Immunocompromised states, which may increase susceptibility to severe infections.
- Exposure to highly virulent pathogens or allergens.
- Delayed or inadequate treatment of underlying conditions.
Symptoms
- Intense redness and swelling of the conjunctiva in the left eye.
- Thick, purulent or mucopurulent discharge.
- Formation of a pseudomembrane on the conjunctiva, which may be adherent or easily removable.
- Sensation of a foreign body or grittiness in the eye.
- Increased tearing or photophobia.
Diagnosis
Diagnosis is typically based on a clinical evaluation, including a detailed history and physical examination of the left eye. The presence of a pseudomembrane, along with associated symptoms like discharge and redness, helps confirm the condition. Laboratory tests, such as cultures or PCR, may be used to identify the underlying cause, especially if infectious etiology is suspected.
Treatment Options
Treatment focuses on addressing the underlying cause and managing symptoms. For bacterial infections, topical or systemic antibiotics may be prescribed. Antiviral medications are used for viral cases, while corticosteroids or antihistamines may be indicated for allergic reactions. Warm compresses and lubricating eye drops can help alleviate discomfort. In severe cases, debridement of the pseudomembrane may be necessary.
Prognosis and Follow-Up
With appropriate treatment, most cases resolve within 1–2 weeks. Follow-up is important to monitor for resolution of symptoms and to adjust therapy if needed. Recurrence or complications, such as corneal involvement, may require additional intervention. Patients should be advised to complete the full course of prescribed medications to prevent relapse.
Complications
- Corneal ulceration or scarring.
- Vision impairment if the cornea is involved.
- Chronic conjunctivitis or persistent inflammation.
- Spread of infection to the other eye or surrounding structures.
Lifestyle & Prevention
- Practice good hand hygiene to avoid spreading infection.
- Avoid touching or rubbing the eyes with unwashed hands.
- Use clean towels and avoid sharing personal items like makeup or eye drops.
- Protect the eyes from irritants, such as smoke or dust.
- Follow prescribed treatment regimens and attend follow-up appointments.
When to Seek Professional Help
Seek immediate medical attention if symptoms worsen, vision changes occur, or there is severe pain, light sensitivity, or discharge. Prompt evaluation is necessary to prevent complications and ensure appropriate management.
Tips for Medical Coders
When coding for pseudomembranous conjunctivitis, left eye (H10.222), ensure documentation specifies the left eye and the presence of a pseudomembrane. Verify that the diagnosis aligns with clinical findings, as this code is specific to the left eye. Avoid using this code for bilateral or unspecified eye involvement; use the appropriate laterality code instead. Document any underlying causes or contributing factors to support the diagnosis.
H10.222 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.